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Sphingolipids are potent lipid second messengers that regulate cell differentiation, migration, survival, and
secretion, and alterations in sphingolipid signaling have been implicated in a variety of diseases. However, how
sphingolipid levels are regulated, particularly in the nervous system, remains poorly understood. Here, we show
that the generation of sphingosine-1-phosphate by sphingosine kinase (SphK) promotes neurotransmitter release.
Electrophysiological, imaging, and behavioral analyses of Caenorhabditis elegans mutants lacking sphingosine
kinase sphk-1 indicate that neuronal development is normal, but there is a significant defect in neurotransmitter
release from neuromuscular junctions. SPHK-1 localizes to discrete, nonvesicular regions within presynaptic
terminals, and this localization is critical for synaptic function. Muscarinic agonists cause a rapid increase in
presynaptic SPHK-1 abundance, whereas reduction of endogenous acetylcholine production results in a rapid
decrease in presynaptic SPHK-1 abundance. Muscarinic regulation of presynaptic SPHK-1 abundance is mediated
by a conserved presynaptic signaling pathway composed of the muscarinic acetylcholine receptor GAR-3, the
heterotrimeric G protein Gaq, and its effector, Trio RhoGEF. SPHK-1 activity is required for the effects of
muscarinic signaling on synaptic transmission. This study shows that SPHK-1 promotes neurotransmitter release
in vivo and identifies a novel muscarinic pathway that regulates SphK abundance at presynaptic terminals.
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Acetylcholine (ACh) is a neuromodulator that is critical
for cognitive, motor, and sensory processes in the brain.
Many of its effects are mediated by muscarinic ACh
receptors (mAChRs), the activation of which can lead to
the regulation of neurotransmitter release from presyn-
aptic terminals (Brown 2010; Drever et al. 2011). How
muscarinic signaling pathways couple to presynaptic
components to modulate neurotransmitter release is
not well understood.
Sphingosine kinases (SphKs) are conserved lipid ki-
nases that catalyze the conversion of sphingosine (SPH)
to sphingosine-1-phosphate (S1P), which are potent bio-
active lipids with important functions in survival, differ-
entiation, migration, and trafficking in diverse cell types
(Spiegel et al. 1998; Sarkar et al. 2005; Hannun and Obeid
2008; Yonamine et al. 2011). SphKs have also been im-
plicated in regulating aspects of neuronal function
and neurotransmitter release (Okada et al. 2009). Gene
knockout of the SphK1 isoform impairs hippocampal
long-term potentiation, spatial learning, and memory,
and nociceptive processing (Mizugishi et al. 2005; Kanno
et al. 2010), and selective inhibition of SphKs reduces
glutamate secretion in cultured neurons (Kajimoto et al.
2007). The generation of S1P by SphKs elicits the secre-
tion of neurotransmitters from a variety of neurons and
neurosecretory cells (Alemany et al. 2001; Brailoiu et al.
2002; Pan et al. 2006; Kajimoto et al. 2007; Olivera 2008)
and modulates sensory neuron excitability (Nicol 2008).
In addition, SPH has been shown to have functions in
synaptic vesicle (SV) exocytosis and SV cycling (Rohrbough
et al. 2004; Nicol 2008; Camoletto et al. 2009; Darios
et al. 2009). Furthermore, SphK1 is concentrated at pre-
synaptic terminals in neuronal cultures (Kajimoto et al.
2007).
Cellular localization studies have revealed that SphK is
transiently and rapidly recruited from cytosolic pools to
cellular membranes, where S1P is produced, by a variety
of extracellular and intracellular factors (Olivera and
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Spiegel 1993; Stahelin et al. 2005; Alemany et al. 2007;
Bryan et al. 2008; Pitson 2011). ACh is a key extracellular
factor that regulates SphK1 membrane translocation. In
lung, kidney, and neuroblastoma cells, mAChR activation
by muscarinic agonists can recruit SphK1 to membranes,
promote S1P production, and induce SphK-dependent
calcium mobilization (Meyer zu Heringdorf et al. 1998;
Young et al. 2003; Pfaff et al. 2005; ter Braak et al. 2009).
At synapses, SphK1 abundance is regulated by neuronal
activity (Kajimoto et al. 2007). However, the molecular
mechanisms underlying its synaptic regulation are not
known.
Here we show that the sole Caenorhabditis elegans
ortholog ofmammalian SphK, sphk-1, is required for proper
neurotransmitter release at neuromuscular junctions
(NMJs). We found that SPHK-1 is concentrated at discrete
subsynaptic regions within presynaptic terminals and
that presynaptic levels of SPHK-1 are critical in promot-
ing synaptic transmission. We found that a conserved
muscarinic signaling pathway composed of the mAChR
GAR-3, the heterotrimeric G protein EGL-30, and UNC-
73/Trio acts in motor neurons to regulate the synaptic
abundance of SPHK-1. Our results identify the regulation
of SphK abundance at presynaptic terminals bymuscarinic
signaling as a novel mechanism by which neurotransmit-
ter release is modulated.
Results
SPHK-1 regulates presynaptic function
C. elegans encodes a single SphK gene, sphk-1, which
shares 49% and 52% amino acid similarity with mam-
malian SphK1 and SphK2, respectively. We previously
found that RNAi knockdown of sphk-1 causes resistance
to paralysis upon aldicarb treatment (Sieburth et al. 2005).
Aldicarb is an acetylcholinesterase inhibitor that causes
an accumulation of ACh in synaptic clefts at NMJs.
Conditions or mutations that reduce ACh release confer
resistance to aldicarb-induced paralysis. We examined
whether sphk-1(ok1097) mutants, which lack the sphk-1
start codon and ;90% of the protein-coding region (http:
//www.wormbase.org), have defects in NMJ function.
Mutants exhibited decreased locomotion rates and re-
sistance to the paralytic effects of aldicarb compared with
wild-type animals (Fig. 1A,B). Expression of a full-length
sphk-1 cDNA transgene under the endogenous sphk-1
promoter restored both locomotion rates and aldicarb
sensitivity of sphk-1 mutants to wild-type levels (Fig.
1A,B), indicating that the NMJ defects observed in sphk-1
mutants are due to loss of sphk-1 activity.
To determine whether sphk-1 function is required pre-
or postsynaptically, we first examined the expression
pattern of a sphk-1 transcriptional reporter in which gfp
expression is under the control of a rescuing sphk-1
promoter fragment. We detected GFP fluorescence in
many neurons, including a majority of cholinergic and
GABAergic motor neurons (Fig. 1D). In addition, GFP
fluorescence was detected in body wall muscles, intes-
tine, and hypodermis. Next, we found that transgenes
expressing full-length sphk-1 cDNA specifically in the
nervous system (using the snb-1 promoter) restored
normal aldicarb sensitivity to sphk-1 mutants (Fig. 1E).
Muscle expression of sphk-1 (using the myo-3 promoter)
also rescued the aldicarb defects, although not as well as
neuronal expression (Fig. 1E; Supplemental Table S1).
Together, these results suggest that sphk-1 primarily acts
in presynaptic neurons for aldicarb responsiveness, but
sphk-1 activity in muscle also contributes to the aldicarb
response. We found that sphk-1 mutants were slightly
more sensitive to the paralytic effects of the muscle
agonist levamisole than wild-type controls and that this
sensitivity was rescued by expressing sphk-1 cDNA
specifically in neurons (Fig. 1C). This suggests that there
is also a modest increase in muscle excitability in sphk-1
mutants, possibly reflecting a compensatory mechanism
triggered by a reduction in presynaptic activity.
We found no differences in the patterning or number
of motor neurons (labeled with the acr-2 promoter-gfp
reporter) in the ventral nerve cord of sphk-1 mutants
compared with wild-type controls (GFP-labeled cells:
34.2 6 0.3 in wild type vs. 34.8 6 0.4 in sphk-1 mutants;
n = 30; P > 0.05). In addition, acute treatment with a selec-
tive SphK inhibitor (SKI) caused a decrease in sensitivity
to aldicarb, albeit less dramatically than sphk-1 mutants
(Fig. 1F). The subtle effect of SKI is presumably due to its
inefficient diffusion into animals, since C. elegans skin is
an efficient barrier tomany compounds (Burns et al. 2010;
Kage-Nakadai et al. 2010). Together, these results suggest
that sphk-1 activity does not impact neuronal develop-
ment or patterning, but rather regulates synaptic function.
SPHK-1 promotes ACh release
To examine ACh release directly, we recorded endoge-
nous and electrically evoked excitatory postsynaptic
currents (EPSCs) from body wall muscles. We found that
the frequency and amplitude of miniature (endogenous)
EPSCs (mEPSC) were similar in sphk-1mutants and wild-
type controls (Fig. 2A), indicating that spontaneous SV
release and muscle responsiveness to ACh were normal.
However, sphk-1 mutants displayed a 34% decrease in
charge transfer following an evoked stimulus compared
with wild type (P < 0.01, Student’s t-test) (Fig. 2B),
suggesting that the total amount of neurotransmitter
released in response to electrical stimulus was lower.
This defect was fully rescued by re-expressing full-length
sphk-1 cDNA in sphk-1 mutants. These results suggest
that the defects in evoked charge transfer are likely to be
due to defects in ACh release from presynaptic terminals,
rather than to postsynaptic defects.
To determine whether there is an underlying defect in
synapse number, synapse composition, or SV cycling in
sphk-1 mutants, we analyzed changes of fluorescently
tagged synaptic proteins that label a variety of different
subsynaptic compartments. Motor axons form en passant
synapses that can be visualized as a series of fluorescent
puncta distributed along the length of axons when labeled
with fluorescently tagged synaptic markers. Quantifica-
tion of synaptic marker abundance at puncta (punctal
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fluorescence), protein marker abundance in between
puncta (axonal fluorescence), the size of puncta (width
fluorescence), and the distance between puncta (inter-
punctal interval) are useful measures of the structural and
functional properties of presynaptic terminals (diagram in
Fig. 2C; Ch’ng et al. 2008).
We first examined whether sphk-1 mutants displayed
changes in synapse number and composition by analyzing
the abundance and distribution of active zone proteins
(UNC-10/RIM1 and SYD-2/liprin) and periactive zone
proteins (SNN-1/synapsin, APT-4/adaptin, and ITSN-1/
intersectin) in the DA class of motor neurons (using the
unc-129 promoter). No changes were observed in the
abundance, size, or number of UNC-10-GFP, SYD-2-GFP,
SNN-1-GFP, APT-4-GFP, or ITSN-1-GFP puncta (Fig. 2D;
Supplemental Table S2), suggesting that the number of
synapses and the synaptic architecture of motor neurons
are normal in sphk-1 mutants.
We next analyzed SV cycling at presynaptic terminals
in sphk-1 mutants by examining the SV proteins SNB-1/
synaptobrevin and RAB-3/Rab3 GTPase. The intensity of
GFP-SNB-1 punctal fluorescence is correlated with the
number of SVs at presynaptic terminals, whereas the
intensity of diffuse GFP-SNB-1 axonal fluorescence is
correlated with the abundance of synaptobrevin in the
plasma membrane (Sieburth et al. 2005; Dittman and
Kaplan 2006; Fernandez-Alfonso et al. 2006; Ch’ng et al.
2008). We observed significant increases in the punctal
fluorescence of both GFP-SNB-1 and YFP-RAB-3 in sphk-
1 mutants compared with wild-type synapses (Fig. 2D).
Similar changes in SNB-1 and RAB-3 distribution have
been detected in mutants lacking the exocytosis protein
UNC-13/Munc13 or UNC-18/Munc18 (Ch’ng et al. 2008).
Synaptic components are generated in the cell body and
selectively targeted to axonal and dendritic specializa-
tions (Ou and Shen 2011). If the increase in GFP-SNB-1
at presynaptic terminals in sphk-1 mutants could be
explained by changes in biogenesis or trafficking of SVs,
then we would also expect alterations in GFP-SNB-1
fluorescence in cell bodies or dendrites in motor neurons
in mutants. However, we observed no changes in GFP-
SNB-1 fluorescence intensity in cell bodies or dendrites in
Figure 1. NMJ defects of sphk-1mutants. (A) Locomotion, measured by body bends per minute, of young adult wild type (26.6 6 1.0),
sphk-1(ok1097) mutants (20.7 6 1.6), and sphk-1 mutants expressing sphk-1 cDNA under the sphk-1 promoter (sphk-1 rescue, 28.7 6
0.8). Asterisks indicate values that differ significantly from wild type, and pound signs indicate differences between groups, as indicated
(significance determined by ANOVA and Tukey post-hoc tests; [ns] not significant; n = 30). (B) Rates of worm paralysis of the indicated
strains upon exposure to the ACh esterase inhibitor aldicarb (1.5 mM). (C) Rates of worm paralysis of the indicated strains upon
exposure to the cholinergic agonist levamisole (200 mM). (D) Coexpression of a sphk-1 promoter fragment driving nuclear-localized GFP
(P.sphk-1-GFP-NLS) and a cholinergic neuron reporter (P.acr-2-mCherry) in ventral cord motor neurons of young adults. Arrows
indicate expression in cholinergic neurons, and the arrowhead indicates expression in GABAergic neurons. Bar, 20 mm. (E) Rates of
paralysis on aldicarb (1.5 mM) of the indicated strains. Neuronal and muscle rescues denote transgenic sphk-1mutants expressing full-
length sphk-1 cDNA under a pan-neuronal promoter (P.snb-1) or body wall muscle promoter (P.myo-3), respectively. (F) Rates of worm
paralysis upon exposure to aldicarb (0.5 mM) after pretreatment with SKI (50 mM) for 2 h. Error bars are 6SEM.
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Figure 2. Synaptic transmission and vesicle cycling defects in sphk-1mutants. (A) Quantification of endogenous mEPSCs in wild-type
(WT), sphk-1mutant, and P.sphk-1 rescue animals. (Top left) Representative traces of mEPSCs. (Top right) Quantification of the mEPSC
frequency: wild-type animals (40.7 Hz 6 2.5 Hz; n = 5), sphk-1 mutant animals (48.8 Hz 6 3.6 Hz; n = 9), and P.sphk-1 rescue animals
(42.5 Hz6 5.6 Hz; n = 6). (Bottom left) Representative traces of the average mEPSC. (Bottom right) Quantification of mEPSC amplitude:
wild-type animals (22.2 pA 6 1.3 pA), sphk-1 mutant animals (19.0 pA 6 1.2 pA), and P.sphk-1 rescue animals (19.1 pA 6 1.2 pA). (B)
Quantification of evoked EPSCs in wild-type, sphk-1 mutant, and P.sphk-1 rescue animals. (Top left) Representative traces of evoked
current. (Top right) Quantification of the peak amplitude: wild-type animals (2.2 nA 6 0.1 nA; n = 8), sphk-1mutant animals (2.0 nA 6
0.2 nA; n = 8), and P.sphk-1 rescue animals (2.1 nA 6 0.2 nA; n = 5). (Bottom left) Quantification of total charge transfer: wild-type
animals (18.8 pC 6 1.6 pC), sphk-1mutant animals (12.4 pC 6 1.4 pC), and P.sphk-1 rescue animals (18.9 pC 6 2.3v). Asterisks indicate
values that differ between the groups shown; (*) P < 0.05. (C) Schematic of the quantification method used to determine the abundance
of fluorescently tagged proteins at synapses (punctal) and between synapses (axonal), synapse size (width), and synapse number
(interpunctal interval [IPI]) of DA motor neurons. (D) Analysis of the abundance of a panel of YFP- or GFP-tagged SV proteins in sphk-1
mutants, normalized to wild type (dotted line). (E, left) Representative images of GFP-tagged synaptobrevin (GFP-SNB-1) in DA motor
neurons in the indicated strains. Motor neuron rescue was performed by expressing cDNA for full-length or a kinase-dead (KD1) sphk-1
under the unc-129 promoter and muscle rescue under the myo-3 promoter. (Right) Quantification of GFP-SNB-1 punctal fluorescence,
normalized to wild type (dotted line). Bar, 10 mm. (F,G) Quantification of GFP-SNB-1 fluorescence in cell bodies (F) and punctal
fluorescence in dendrites (G) of wild type and sphk-1 mutants. Values are normalized to wild type. For all quantification, asterisks
indicate values that differ significantly from wild type, and pound signs indicate values that differ from sphk-1(ok1097)mutants ([*] P <
0.05; [**] P < 0.005; [#] P < 0.05; one-way ANOVA and Tukey’s post-hoc tests; [ns] not significant).
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sphk-1mutants (Fig. 2F,G), suggesting that SPHK-1 func-
tions to promote the release of SVs from presynaptic
terminals.
The increase in synaptic fluorescence of GFP-SNB-1
observed in sphk-1 mutants was completely rescued
when sphk-1 cDNA was expressed specifically in motor
neurons (using the unc-129 promoter) (Fig. 2E). Interest-
ingly, we observed that re-expression of sphk-1 cDNA in
body wall muscles partially rescued the sphk-1 mutant
phenotype. Thus, sphk-1 functions both cell-autono-
mously in motor neurons and non-cell-autonomously in
muscles to promote SV release.
SPHK-1 functions at presynaptic terminals
Given the role of SPHK-1 in regulating neurotransmitter
secretion, we next determined whether it was concen-
trated at sites of SV release. We examined the subcellular
localization of a fully functional fusion of GFP-tagged
SPHK-1 (SPHK-1-GFP) in cholinergic motor neurons.
Fluorescence was observed in cell bodies in addition to
axons, where SPHK-1-GFP adopted a highly punctate
pattern of fluorescence (Fig. 3). SPHK-1-GFP puncta were
observed near the SV proteins SNB-1/synaptobrevin and
RAB-3/Rab3 (Fig. 3A; data not shown), indicating that
SPHK-1 is enriched at presynaptic terminals. Interest-
ingly, not all SNB-1 puncta were associated with a corre-
sponding SPHK-1 punctum, and SPHK-1 puncta were
generally much smaller and more distinct than SV
puncta. SPHK-1-GFP axonal fluorescence (fluorescence
between puncta) was not detectable above background,
suggesting that there is very little nonsynaptic SPHK-1 in
these neurons. To test whether SPHK-1 directly associ-
ates with SVs, we examined the localization of SPHK-1-
GFP in mutants with altered SV distribution. SPHK-1-
GFP remained punctate in mutants lacking UNC-104/
KIF1A (Fig. 3B), a kinesin motor protein necessary for SV
axonal transport (Hall and Hedgecock 1991). In addition,
the intensity, size, and number of SPHK-1-GFP puncta
were not altered in mutants with increased (unc-13) or
decreased (unc-57/endophilin) presynaptic SV pools
(Ch’ng et al. 2008), indicating that localization of SPHK-1
in axons is not dependent on SVs (Fig. 3B; Supplemental
Table S3). We next tested whether SPHK-1 localizes to
other subsynaptic regions within presynaptic terminals.
We found that SPHK-1 puncta were mostly apposed to
but did not colocalize with the active zone marker UNC-
10/RIM1, which marks sites of SV release (Fig. 3C), or the
dense core vesicle marker NLP-21/neuropeptide-like pro-
tein (Fig. 3D). SPHK-1 puncta colocalized more consis-
tently, although not completely, with the periactive zone
proteins GSNL-1/gelsolin, ITSN-1/intersectin, and SNN-
1/synapsin (Fig. 3E; data not shown). Periactive zones are
regions of presynaptic membranes that contain proteins
involved in endocytosis and actin regulation and may be
specialized for SV recycling. Together, these data suggest
that SPHK-1 is not directly associated with SVs but
instead is concentrated on regions of presynaptic mem-
branes that are likely to be close to periactive zones.
If SPHK-1-GFP localization at presynaptic terminals is
important for its function in promoting ACh release, then
we expect that altering the abundance of SPHK-1 at
synapses would cause corresponding changes in synaptic
transmission. Consistent with this idea, we found that
Figure 3. SPHK-1 localizes to presynaptic terminals. (A) Representative images showing the localization pattern of SPHK-1-GFP and
SNB-1/synaptobrevin (mCherry-SNB-1) in adult DA axons. (B) Images of SPHK-1-GFP distribution in mutants lacking the SV
trafficking protein unc-104/kinesin KIF1A or the SV cycling proteins unc-13/Munc13 and unc-57/endophilin. (C–E) Representative
images showing the localization of SPHK-1-mCherry with UNC-10/RIM1 (UNC-10-GFP), NLP-21/neuropeptide (NLP-21-YFP), or
GSNL-1/gelsolin (GSNL-1-GFP). Bar, 10 mm.
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animals overexpressing wild-type SPHK-1 transgenes
displayed significantly increased sensitivity to aldicarb
compared with nontransgenic controls (Fig. 4A). We
confirmed that animals overexpressing SPHK-1 had in-
creased SPHK-1 abundance at presynaptic terminals by
comparing SPHK-1-GFP punctal fluorescence from ani-
mals expressing one copy of the transgene (from heterozy-
gotes) to two copies of the transgene (from homozygotes).
We found an increase in peak fluorescence of ;214% (P <
0.001, Student’s t-test) in animals expressing two copies of
the SPHK-1-GFP transgene. These results suggest that
increasing SPHK-1 dosage results in corresponding in-
creases in both SPHK-1 synaptic abundance and aldicarb
hypersensitivity.
Conversely, we predict that decreasing SPHK-1 abun-
dance at synapses would also alter synaptic transmission.
To test this, we interfered with the ability of SPHK-1 to
translocate to synapses bymutating its calcium/calmodulin
(CaM)-binding site. Mutations in the CaM-binding site
of mammalian SphK have been reported to decrease
translocation of SphK to membranes but to have no effect
on its catalytic activity (Sutherland et al. 2006; Jarman
et al. 2010). We found that GFP-tagged SPHK-1 transgenes
lacking the functional CaM-binding site [SPHK-1(DCaM)-
GFP] were expressed at levels in the cell bodies of neurons
similar to wild-type transgenes [cell body fluorescence was
2280 6 243 arbitrary units for SPHK-1(WT)-GFP and
2561 6 222 arbitrary units for SPHK-1(DCaM)-GFP;
n = 20]. However, peak fluorescence at synapses was sig-
nificantly decreased compared with SPHK-1-GFP con-
trols (Fig. 4B,C). Importantly, SPHK-1(DCaM) transgenes
failed to rescue the aldicarb resistance of sphk-1mutants
(Fig. 4A, hatched bars), implying that the CaM-binding site
is necessary for both the translocation and function of
SPHK-1 at synapses. Interestingly, SPHK-1(DCaM)-GFP
puncta were significantly wider than SPHK-1 puncta
(0.89 6 0.02 mm for wild type and 1.24 6 0.05 mm for
DCaM; P < 0.001) (Fig. 4B,C), and colocalization with
SPHK-1-mCherry revealed that SPHK-1(DCaM)-GFP
puncta extended beyond the regions normally occupied
Figure 4. Levels of SPHK-1 at synapses affect aldicarb responsiveness. (A) Rates of worm paralysis at 60 and 80 min in aldicarb (1.0
mM) of wild-type (WT) animals, sphk-1 mutants, transgenic wild-type animals expressing sphk-1 cDNA under the pan neuronal snb-1
promoter (wild-type + sphk-1 transgene), and sphk-1mutants expressing either wild-type (sphk-1 + sphk-1 transgene) or mutated [sphk-
1 + sphk-1(DCaM) transgene] sphk-1 cDNA under the pan neuronal snb-1 promoter. (B, top) Schematic of SPHK-1 indicating the five
conserved domains (C1–C5) and the CaM-binding site. The sequence mutated in SPHK-1(DCaM) is underlined. (Bottom) Represen-
tative images of GFP tagged to wild-type SPHK-1 [SPHK-1(WT)] or to SPHK-1 with its CaM-binding site mutated [SPHK-1(DCaM)]. (C)
Quantification of the punctal fluorescence and width in wild-type animals expressing either SPHK-1(WT)-GFP or SPHK-1(DCaM)-GFP
transgenes. (**) P < 0.005, Student’s t-test. (D) Images showing the localization pattern of SPHK-1(WT)-mCherry with SPHK-1(DCaM)-
GFP coexpressed in DA neurons. Arrowheads indicate SPHK-1(DCaM)-GFP puncta with greater widths compared with SPHK-1-
mCherry. Bars, 10 mm. Error bars are 6SEM.
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by SPHK-1(WT)-mCherry (Fig. 4D). Together, these re-
sults indicate that maintaining a highly concentrated and
spatially restricted distribution of SPHK-1 at synaptic (or
other) membranes may be critical for its function.
S1P generation by SPHK-1 regulates neurotransmission
To determine whether the synaptic defects seen in sphk-1
mutants arise from altered SPH or S1P levels, we exam-
ined the effects of catalytically inactive sphk-1 on SPHK-1
localization and function. We generated two kinase-dead
(KD) sphk-1 variants that contain amino acid substitutions
in critical regions of the catalytic domain: SPHK-1(KD1)
contains a five-amino-acid substitution in a conserved
region (SGDGL to AAAAA) in the kinase domain reported
to be critical for nucleotide binding and activity of mam-
malian SphK1 (Pitson et al. 2002), and SPHK-1(KD2)
contains a GSGN-to-DDDD mutation, which has been
shown to block kinase activity in Drosophila SphK
(Yonamine et al. 2011). Transgenes expressing either of
the kinase-dead variants failed to rescue the aldicarb re-
sistance defects of sphk-1mutants (Supplemental Fig. S1).
In addition, we found that although the SPHK-1(KD1)
variant adopted a punctate pattern of fluorescence in
axons similar to wild-type SPHK-1-GFP (data not shown),
it failed to rescue the SV cycling defects of sphk-1 mu-
tants (Fig. 2E). Thus, the kinase activity of SPHK-1 is nec-
essary to restore proper aldicarb responsiveness and SV
cycling to sphk-1 mutants.
Analysis of whole-worm extracts by mass spectrome-
try has shown a 10-fold increase in SPH levels in sphk-1
mutants (Menuz et al. 2009). However, for reasons that
are not entirely clear, S1P and its derivatives have been
difficult to reliably detect from these extracts (Menuz
et al. 2009; D Sieburth, unpubl.). To circumvent this
limitation, we examined genetic interactions between
sphk-1 and hyl-1/ceramide (CER) synthase mutants. CER
synthase is an enzyme that converts SPH to CER (Fig. 5A).
hyl-1mRNA is expressed inC. elegansmotor neurons (Fox
et al. 2005). Like sphk-1 mutants, hyl-1/CER synthase
mutants have increased SPH levels, as determined bymass
spectrometry (Menuz et al. 2009). If increased SPH levels
cause the synaptic transmission defects associated with
sphk-1 mutants, then hyl-1 mutants should display a re-
duction in locomotion rates similar to sphk-1 mutants.
However, we found that hyl-1 mutants displayed signifi-
cantly increased locomotion rates compared with wild-
type animals (Fig. 5B). These results indicate that high SPH
levels are not likely to contribute to the defects seen in
sphk-1 mutants. On the other hand, if S1P production
were necessary for synaptic function, then we would
expect sphk-1 mutations to suppress the locomotion
defects seen in hyl-1mutants because the doublemutants
can no longer make S1P. Consistent with this, we found
that sphk-1;hyl-1 double mutants had locomotion rates
that were similar to sphk-1 mutants (Fig. 5B). Together,
these results suggest that the synaptic transmission de-
fects of sphk-1 mutants are likely to result from lack of
S1P production by SPHK-1.
Endogenous ACh regulates SPHK-1 abundance
at synapses
In C. elegans, two opposing heterotrimeric G proteins
modulate neurotransmission at the NMJ: egl-30/Gaq and
goa-1/Gao, which have excitatory and inhibitory effects,
respectively (Perez-Mansilla and Nurrish 2009). How-
ever, the G-protein-coupled receptors (GPCRs) activating
these G proteins in neurons and the mechanisms cou-
pling G protein activation to neurotransmitter release are
not well understood.We tested whether SPHK-1might be
a downstream component of either of these pathways in
motor neurons. We first examined whether activation
of these G proteins using GPCR agonists could alter the
synaptic abundance of SPHK-1-GFP at presynaptic ter-
minals. We found that acute (2-h) treatment of animals
with arecoline, a muscarinic agonist that activates egl-30/
Gaq (Lackner et al. 1999), caused a significant increase in
SPHK-1-GFP punctal fluorescence (Fig. 6A) but did not
alter punctal width or density (Supplemental Table S3). In
contrast, serotonin treatment, which activates goa-1/Gao
(Nurrish et al. 1999), had no effect on any parameter
measured for SPHK-1-GFP localization or abundance
(Fig. 6A; Supplemental Table S3).
Previous studies in C. elegans have suggested that
arecoline treatment causes aldicarb hypersensitivity by
promoting the recruitment of the UNC-13 to synapses
(Lackner et al. 1999). Therefore, we wondered whether
the alterations in SPHK-1 abundance following arecoline
treatment could be a secondary consequence of areco-
Figure 5. S1P is necessary to promote
neurotransmission. (A) Diagram of the
sphingolipid metabolism pathway and its
enzymes. (B) Quantification of body bends
per minute in indicated strains (wild type
[WT], 28.5 6 1.2; sphk-1, 21.1 6 0.8; hyl-1,
32.3 6 0.8; hyl-1;sphk-1, 22.9 6 0.8; [*] P <
0.01 compared with wild type; [#] P < 0.01
compared between the indicated groups;
significance was determined by ANOVA
and Tukey’s post-hoc tests). Bars, 10 mm.
Error bars are 6SEM.
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Figure 6. GAR-3 mAChR activation in motor neurons regulates SPHK-1 abundance. (A, left) Representative images of SPHK-1-GFP
following 2 h of exposure to plates with M9 (control), arecoline (15 mM), or serotonin (10 mM). (Right) Quantification of the SPHK-1-
GFP punctal fluorescence (control vs. arecoline, [*] P < 0.05; control vs. serotonin, P > 0.05; ANOVA and Tukey’s post-hoc tests). (B)
Rates of paralysis on aldicarb (1.0 mM) for wild-type animals compared with sphk-1 with or without arecoline treatment. (C,D)
Representative images (left) and quantification (right) of SPHK-1-GFP in the indicated strains. Quantification of SPHK-1-GFP punctal
fluorescence was normalized to wild type (dotted line; [*] P < 0.05; Student’s t-test). (E,F) Rates of paralysis on aldicarb (1.0 mM) for
wild-type animals compared with gar-1/mAChR (E) or gar-3/mAChR (F) mutants with and without acute arecoline treatment. (G)
Representative images (left) and quantification (right) of changes in SPHK-1-GFP punctal fluorescence following arecoline treatment (2
h) in the indicated strains. Neuronal rescue denotes gar-3 mutants expressing a P.unc-129-gar-3 cDNA transgene. Asterisks indicate
values that differ significantly from wild type ([*] P < 0.01; [#] P < 0.01; ANOVA and Tukey’s post-hoc tests). Bars, 10 mm. Error bars are
6SEM for aldicarb curves or propagated SEM for quantitative imaging.
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line’s effect on presynaptic activity. To test this idea, we
examined whether SPHK-1-GFP fluorescence changes in
mutants with altered ACh secretion fromNMJs or altered
electrical activity. We found no significant changes in
SPHK-1-GFP punctal fluorescence in mutants that either
increase (tomo-1/tomosyn or cpx-1/complexin) (Fig. 6C)
or decrease (unc-13/Munc13 or unc-18/Munc18) (Fig. 7B;
Supplemental Table S3) ACh secretion (Richmond et al.
1999; Weimer et al. 2003; Madison et al. 2005; Gracheva
et al. 2006; Vashlishan et al. 2008; Hobson et al. 2011;
Martin et al. 2011). In contrast, mutants expressing
a constitutively active slo-1/BK potassium channel that
inhibits neuronal activity (Richmond et al. 2001; Q Liu
et al. 2007) displayed reduced SPHK-1-GFP punctal fluo-
rescence (Fig. 6C). Thus, the effect of arecoline treatment
on SPHK-1 abundance is not a secondary effect of
alterations in SV release, but rather is likely to reflect
the direct recruitment of SPHK-1 to motor synapses by
muscarinic signaling. In addition, the recruitment of
SPHK-1 presynaptic terminals is likely to be dependent
on presynaptic activity.
Does endogenously produced ACh regulate SPHK-1
abundance? To test this, we examined animals deficient
in ACh biosynthesis for effects on SPHK-1-GFP punctal
fluorescence. cha-1/ChAT encodes the only C. elegans
ortholog of choline acetyltransferase. cha-1/ChAT-null
mutants are born paralyzed and die due to starvation,
presumably due to the lack of ACh production (Rand
1989). However, cha-1/ChAT (p1182) temperature-sensi-
tive mutants are viable but become paralyzed within 15
min of being shifted from 20°C to 25°C (Rand 1989). We
found that shifting cha-1/ChAT mutants expressing
SPHK-1-GFP transgenes for 15, 30, or 60 min to 25°C
resulted in significant decreases in SPHK-1-GFP punctal
fluorescence compared with temperature-shifted wild-
type controls (Fig. 6D). In contrast, cha-1/ChAT mutants
that were not temperature-shifted were not significantly
different from wild-type controls (Fig. 6D). Together,
Figure 7. Regulation of SPHK-1 synaptic abundance by the Gaq signaling pathway. (A,B) Representative images and quantification of
SPHK-1-GFP fluorescence of DA motor axons in the indicated strains. (C,D) Rates of paralysis on aldicarb (1.0 mM) for the indicated
strains. For unc-73, the ce362mutation was used. The indicated animals were pretreated with arecoline (15 mM in M9) or control (M9)
for 2 h. (E) Model of the muscarinic signaling pathway in C. elegans cholinergic motor neurons that regulates SPHK-1 synaptic
abundance and neurotransmitter release. Established model of the G-protein pathway in C. elegans motor neuron (Perez-Mansilla and
Nurrish 2009), with novel components identified in this study shown in boxes. For quantification of SPHK-1-GFP, values are normalized to
wild type (represented by dotted line); (*) P < 0.05 (Student’s t-test). Bars, 10 mm. Error bars are 6SEM for aldicarb curves, or 6propagated
SEM for quantitative imaging.
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these results strongly support the idea that ACh can
regulate SPHK-1 abundance bidirectionally: Muscarinic
agonists can increase SPHK-1 synaptic abundance,
whereas reductions in endogenously produced ACh de-
crease SPHK-1 synaptic abundance. Furthermore, these
results show that ACh canmodify SPHK-1 abundance at
rapid timescales (in as little as 15 min) and therefore is
likely to act post-translationally to regulate synaptic
SPHK-1 levels.
gar-3/mAChR mediates the effects of ACh and acts
cell-autonomously
To identify the mAChR that mediates the effects of
arecoline on SPHK-1 abundance, we tested the effects of
mAChR family members on SPHK-1 recruitment. gar-1
and gar-3 encode mAChRs homologous to M1, M3, and
M5 classes of mammalian muscarinic receptors and are
predicted to couple to egl-30/Gaq. We found that both
gar-1 and gar-3 putative null mutants were weakly re-
sistant to paralysis by aldicarb (Fig. 6E,F). However, gar-3/
mAChRmutants were mostly unresponsive to the effects
of arecoline, whereas gar-1/mAChR mutants responded
similarly towild-type controls. Interestingly, gar-3/mAChR
mutations also blocked the arecoline-induced increase in
SPHK-1-GFP punctal fluorescence (Fig. 6G). These results
suggest that gar-3/mAChR is required for the muscarinic
agonist-mediated effects on aldicarb hypersensitivity and
SPHK-1 synaptic recruitment. gar-3/mAChR mRNA is
enriched in cholinergic motor neurons (Fox et al. 2005),
and transcriptional reporters show gar-3/mAChR expres-
sion in muscles, the pharynx, motor neurons, and some
neurons in themale tail (Steger and Avery 2004; Y Liu et al.
2007). We found that expression of gar-3/mAChR cDNA
specifically in motor neurons (using the unc-129 promoter)
was sufficient to fully restore arecoline-induced increases
in SPHK-1-GFP punctal fluorescence to gar-3/mAChR
mutants (Fig. 6G). Thus, gar-3/mAChR acts cell-autono-
mously in motor neurons to recruit SPHK-1 to release sites
in response to cholinergic agonists.
If SPHK-1 recruitment to presynaptic terminals by
muscarinic signaling were important for the effects of
GAR-3 activation on neurotransmission, then we would
expect that the aldicarb hypersensitivity caused by arec-
oline treatment would be attenuated in sphk-1 mutants.
Consistent with this idea, we found that sphk-1 mutants
were significantly less responsive to arecoline treatment
compared with wild-type controls (Fig. 6B). Taken to-
gether, our data indicate that the recruitment of SPHK-1
by arecoline is functionally important for the effects of
muscarinic signaling on synaptic transmission.
Gaq-Trio signaling regulates synaptic SPHK-1
abundance
GAR-3/mAChR has been shown to activate the hetero-
trimeric G protein EGL-30/Gaq in certain cells in C.
elegans (Steger and Avery 2004; Y Liu et al. 2007); thus,
we predicted that GAR-3/mAChR couples to EGL-30/Gaq
in motor neurons. Consistent with this, egl-30/Gaq loss-
of-function mutations significantly reduced the synaptic
fluorescence intensity of SPHK-1-GFP compared with
wild-type controls (Fig. 7A). Conversely, constitutively
active egl-30/Gaq mutations [egl-30(gf)] significantly in-
creased SPHK-1-GFP punctal fluorescence, indicating that
egl-30/Gaq signaling regulates SPHK-1 synaptic abun-
dance in motor neurons. The effects of egl-30(gf) on
SPHK-1 abundance were not blocked by unc-18/Munc18
mutations (Fig. 7B), confirming that SPHK-1 synaptic
recruitment is not a secondary effect of egl-30/Gaq
signaling on SV exocytosis. We also found that sphk-1
mutations partially block the aldicarb hypersensitivity of
egl-30(gf) mutants (Fig. 7C), confirming that sphk-1 is
a functionally relevant downstream target of the GAR-3/
mAChR-EGL-30/Gaq pathway in these neurons.
EGL-30/Gaq promotes neurotransmission at the NMJ
by activating two pathways through distinct downstream
effectors: UNC-73/Trio RhoGEF and EGL-8/phospholi-
pase C b (PLCb) (Perez-Mansilla and Nurrish 2009). We
found that either unc-73/Trio RhoGEF or egl-8/PLCb
putative null mutations partially block the effects of
arecoline treatment on aldicarb sensitivity (Fig. 7D),
suggesting that both pathways contribute to muscarinic
signaling in motor neurons. However, unc-73/Trio RhoGEF
but not egl-8/PLCb mutants decreased SPHK-1-GFP
punctal fluorescence compared with controls (Fig. 7A).
Trio is a conserved guanine nucleotide exchange factor
(GEF) family member that regulates axon guidance, syn-
aptic growth, and neuronal function (Bateman and Van
Vactor 2001; Williams et al. 2007; Ball et al. 2010). UNC-
73/Trio RhoGEF is an UNC-73 isoform that has a single
Rho GTPase GEF domain that activates RHO-1/RhoA to
promote NMJ function (McMullan et al. 2006; Williams
et al. 2007). These results suggest that the unc-73/Trio
RhoGEF branch of the egl-30/Gaq signaling pathway
mediates arecoline-dependent recruitment of SPHK-1 to
synapses.
Our results show that egl-8/PLCb does not positively
regulate the abundance of SPHK-1-GFP at release sites.
Consistent with this, mutations in signaling components
acting downstream from EGL-8/PLCb, including PKC-1/
protein kinase C and DGK-1/diacylglycerol kinase, did
not change SPHK-1-GFP punctal fluorescence compared
with wild-type controls (Fig. 7A). Taken together, these
data indicate that the EGL-30/Gaq effector UNC-73/Trio
but not the EGL-8/PLCb or the DAG-PKC-1/PKC path-
way positively regulates the abundance of SPHK-1-GFP at
presynaptic terminals. Our data support a model (Fig. 7E)
whereby ACh-activated mAChR–Gaq–Trio signaling re-
cruits SPHK-1 to presynaptic release sites to positively
modulate neurotransmitter release.
Discussion
Here we describe a new presynaptic component—the C.
elegans SphK1 and SphK2 ortholog sphk-1—that pro-
motes neurotransmitter release from motor terminals.
SPHK-1 is concentrated at presynaptic membranes,
where its abundance is regulated by endogenous ACh.
ACh activates a conserved muscarinic signaling pathway
in presynaptic motor neurons, consisting of a mAChR,
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Gaq/11, and Trio RhoGEF, an effector of Gaq. Our findings
suggest that the regulation of SphK at sites of neurotrans-
mitter release may be an important mechanism by which
synaptic function is modulated by ACh. Furthermore,
identifying regulators of sphingolipidmetabolism enzymes
is important, as misregulation of sphingolipids is im-
plicated in neurological diseases such as Alzheimer’s,
Parkinson’s, and Niemann Pick C (Okada et al. 2009).
SPHK-1 positively regulates ACh release
Our data support the idea that SPHK-1 promotes ACh
secretion. First, electrophysiological recordings show that
sphk-1 mutants had reduced total charge transfer evoked
by electrical stimulation. The amplitude and kinetics of
spontaneous mEPSCs were similar to wild type, implying
that muscle response to quantal release was not altered.
Second, the accumulation of the SV markers SNB-1/
synaptobrevin and RAB-3/RAB3 in sphk-1 mutant syn-
apses suggest a failure to efficiently release SVs from
presynaptic terminals. Third, the aldicarb resistance and
SV cycling defects of sphk-1 mutants were each rescued
by presynaptic expression of sphk-1. Taken together, these
results strongly suggest that SPHK-1 potentiates synaptic
transmission by increasing ACh release.
Interestingly, culturedmammalian neurons lacking the
presynaptic calcium-binding protein DOC2a or those
overexpressing the SNARE-binding protein snapin ex-
hibit a decreased total charge transfer defect (Pan et al.
2009; Yao et al. 2011), similar to that seen in sphk-1
mutants. The doc2a mutant phenotype is due to im-
paired asynchronous neurotransmitter release, which
represents the slower calcium-dependent component of
evoked release. It is intriguing to speculate that SPHK-1
may be required during asynchronous release for the
recruitment of reserve vesicles that contribute to sus-
tained SV exocytosis. The accumulation of SVs at pre-
synaptic terminals in sphk-1 mutants may represent an
accumulation of a pool of SVs that normally undergoes
slow asynchronous release.
Sphingolipid signaling and metabolism at synapses
SPHK-1 is enriched at synapses and is likely to be associ-
ated with a region of the presynaptic plasma membrane
near periactive zones for the following reasons. First,
SPHK-1-GFP puncta occupied a small area within pre-
synaptic terminals, as visualized by SNB-1-GFP. Second,
SPHK-1-GFP remained punctate in unc-104/KIF1a mu-
tants, in which SVs are no longer trafficked to axons. Third,
mutants in which SV recycling is altered (unc-57/endophil-
lin or unc-13/MUNC13 mutants) did not affect SPHK-1
abundance at presynaptic terminals. Finally, SPHK-1 colo-
calized most consistently but not completely with three
different periactive zone markers, but less well with active
zone proteins or dense core vesicles. Interestingly, mam-
malian SphK coimmunoprecipitates with the endocytosis
proteins clathrin and Bin-1 (amphyphysin2) inmurinemast
cells (Urtz et al. 2004), and S1P binds the actin severing
protein gelsolin (Bucki et al. 2010).
Our genetic evidence suggests that S1P but not SPHmay
promote SV secretion at motor terminals. First, sphk-1
transgenes that abolish its catalytic activity in motor
neurons failed to rescue the aldicarb resistance and SV
cycling defects of sphk-1mutants, even though the protein
still localized to presynaptic terminals. Second, hyl-1/CER
synthase mutants, which have increased SPH levels
(Menuz et al. 2009), displayed opposite locomotion pheno-
types compared with sphk-1 mutants. Third, genetically
increasing SPH levels while blocking generation of S1P (in
hyl-1;sphk-1 double mutants) recapitulated the reduced
locomotion defect of sphk-1mutants. These results suggest
that the neurotransmission defects associated with sphk-1
mutants cannot be accounted for by elevated SPH levels
alone, but rather are likely due to reduced S1P generation.
Consistent with this idea, sphk-1 mutants are more sensi-
tive to radiation-induced germ cell apoptosis, a phenotype
that is attributed to reduced S1P production (Deng et al.
2008). Our results are also consistent with other studies in
which exogenous application of S1P increases neurotrans-
mitter secretion in many cell types, including neurons
(Brailoiu et al. 2002; Pan et al. 2006; Kajimoto et al. 2007),
and the finding by Darios et al. (2009) that SPH mediates
SNARE complex formation. This suggests that these two
sphingolipids may both promote vesicle release and act via
either distinct or codependent mechanisms.
S1P is known to be either a secreted ligand that activates
extracellular receptors (of the S1PR/EDG family) or an
intracellular second messenger that targets cytoplasmic pro-
teins (Spiegel 2000; Leclercq and Pitson 2006; Rosen et al.
2009). We found that sphk-1 acts both cell-autonomously
in motor neurons and non-cell-autonomously in muscles
to regulate aldicarb responsiveness and SV cycling. How-
ever, the C. elegans genome does not encode obvious
S1PR/EDG family orthologs. Thus, we speculate that S1P
generated in neurons acts as an intracellular messenger on
synaptic targets within motor neurons to promote release.
In addition, S1P generated in muscles may be able to
diffuse to motor neurons, but likely acts by a mechanism
independent of known S1P receptors. S1P can interactwith
multiple intracellular targets, including transient receptor
potential (TRP) channels, store-operated calcium channels,
inositol triphosphate receptors, and calcium-activated po-
tassium channels (BKCa) (Ghosh et al. 1994; Mattie et al.
1994; Flemming et al. 2006; Kim et al. 2006). Although
these targets are found in neurons, the functional signifi-
cance of their interaction with S1P on neurotransmitter
release is not known. Recently, intracellular S1P has also
been shown to directly associate with and modulate the
activities of the E3 ubiquitin ligase TRAF2 and the histone
deacetylases (HDAC1 and HDAC2) (Hait et al. 2009;
Alvarez et al. 2010). HDAC2 regulates synaptic plasticity
and memory formation in mouse models (Guan et al.
2009), raising the possibility that regulation of histone
deacetylase activity by S1P may contribute to plasticity.
Muscarinic regulation of SPHK-1 synaptic abundance
We found that experimentally manipulating levels of
SPHK-1 at synapses led to corresponding changes in
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aldicarb responses. Overexpressing SPHK-1 resulted in
increased SPHK-1 abundance at synapses and conferred
aldicarb hypersensitivity to animals. In contrast, reduc-
ing SPHK-1 abundance by ;50% without reducing cata-
lytic activity (by deleting the CaM-binding domain of
SPHK-1) abolished its ability to rescue the aldicarb re-
sistance of sphk-1 mutants. Together, these observations
suggest that presynaptic levels of SPHK-1 may be critical
for its function in synaptic transmission.
ACh was necessary and sufficient for SPHK-1 synaptic
recruitment. Treatment of wild-type animals with areco-
line resulted in an ;30% increase in SPHK-1 punctal
fluorescence, whereas reduction of endogenously produced
ACh (in cha-1/ChAT temperature-sensitive mutants)
resulted in an;30% decrease in SPHK-1-GFP punctal fluo-
rescence. These changes are not secondary consequences
of altering cholinergic transmission because mutations
that either increase or decrease ACh secretion (in cpx-1/
complexin or unc-13/Munc13 mutants, respectively) did
not change SPHK-1 abundance. Thus, the effects of ACh on
SPHK-1 abundance reflect the specific recruitment of
SPHK-1 by ACh signaling. The effects of ACh and areco-
line on SPHK-1 recruitment were relatively rapid: We
observed a decrease in punctal fluorescence within 15
min of temperature shift of cha-1/ChAT mutants. These
results are consistent with the established notion that
SphKmembrane abundance is regulated by its recruitment
to membranes from cytoplasmic pools (Pitson et al. 2003).
However, we cannot rule out other mechanisms that
might regulate synaptic SPHK-1 abundance at synapses,
such as changes in the stability of synaptic SPHK-1 or its
diffusion within axonal membranes. Importantly, the ef-
fect of arecoline on aldicarb responsiveness was dramati-
cally reduced by sphk-1mutations, indicating that SPHK-1
activity is required, at least in part, for the effects of
muscarinic signaling on synaptic transmission.
A previous study has shown that depolarization of
cultured neurons recruits SphK to axonal membranes
(Kajimoto et al. 2007). Consistent with this, we found that
presynaptic calciummay regulate SPHK-1 synaptic recruit-
ment, since removing the CaM-binding domain of SPHK-1
reduced its synaptic abundance. In addition, reducing pre-
synaptic activity [in slo-1(gf)/BK channel mutants] also
reduced SPHK-1-GFP synaptic localization. Therefore, depo-
larizing presynaptic terminals is important for SPHK-1
synaptic recruitment, but whether it is required for musca-
rinic-mediated regulation of SPHK-1 remains unclear.
Trio RhoGEF regulates SPHK-1 abundance
We found that the M1/M3/M5 class of mAChR, gar-3,
acts cell-autonomously in motor neurons to mediate the
effects of arecoline on SPHK-1 abundance at presynaptic
terminals. In mammals, activation of the M1 and M3
classes of mAChRs results in activation of Gaq, which in
turn primarily activates PLC. Although we found that
EGL-8/PLCb mediates some of the effects of muscarinic
agonists at synapses, our data do not support a role for
EGL-8/PLCb in recruiting SPHK-1 to release sites, since
egl-8/PLCbmutations (or mutations in dgk-1/diacylglycerol
kinase or pkc-1/protein kinase C) did not reduce SPHK-1-
GFP punctal fluorescence. Interestingly, SPHK-1-GFP
fluorescence increased in egl-8/PLCb mutants, suggest-
ing that egl-8/PLCb may negatively regulate SPHK-1
localization. PLCb has Gaq GAP activity (Ross 2011),
suggesting that EGL-30/Gaq may be able to activate
UNC-73/Trio in egl-8/PLCb mutants. Alternatively, EGL-
8/PLCb may compete with UNC-73/Trio for activation by
EGL-30/Gaq, which may lead to an enhancement of UNC-
73/Trio signaling in the absence of egl-8/PLCb.
We identified an alternative Gaq effector, unc-73/Trio,
that acts downstream from mAChR and egl-30/Gaq to
regulate SPHK-1 abundance. Trios comprise a large fam-
ily of proteins with diverse functions that act by regulat-
ing GTPases of the Rac and Rho family. Of note, Kalirin 7,
a Trio family member, is required for synaptic function of
hippocampal neurons and for peptide secretion (Mains
et al. 1999; Ma et al. 2008). In C. elegans, the unc-73/Trio
locus encodes six isoforms, which differ in the number of
GEF domains and their tissue distributions. Our results
show that a mutation that specifically disrupts the
RhoGEF domain of unc-73, which is found within the
neuronally expressed UNC-73E isoform (Steven et al.
2005), reduces SPHK-1 at presynaptic terminals. Rho
GTPase activity is implicated in recruiting UNC-13/
Munc13 to synapses (McMullan et al. 2006), and specific
loss of Trio’s Rho GTPase activity decreases neuromus-
cular function (Steven et al. 2005; Williams et al. 2007).
Interestingly, M3mAChR stimulation has been shown to
activate p114-RhoGEF (Blomquist et al. 2000; Rumenapp
et al. 2001) andM1mAChR to activate leukemia-associated
RhoGEF (LARG) (Booden et al. 2002). Thus, utilization of
RhoGEFs may be a universal mechanism by which cholin-
ergic signaling regulates cellular function. However, other
pathways in addition to unc-73/Trio are likely to contribute
to the synaptic localization of SPHK-1, since mutations in
egl-30/Gaq or unc-73/Trio components reduced, but did not
eliminate, synaptic abundance of SPHK-1-GFP.
Our results point to a model in which the muscarinic
signaling pathway consisting of GAR-3/mAChR, EGL-
30/Gaq, and UNC-73/Trio recruits SPHK-1 to presynap-
tic membranes near sites of vesicle release. SPHK-1
recruitment leads to local production of S1P, which in
turn binds to one or more unidentified synaptic targets to
promote neurotransmitter secretion. By regulating rela-
tive levels of SPH and S1P near periactive zones, SPHK-1
may be involved in coupling exocytosis and endocytosis
during activity-modulated synaptic transmission. It will
be important to identify the endogenous source of ACh
that promotes SPHK-1 synaptic recruitment as well as
the synaptic targets of S1P that mediate the effects of
ACh on SV release.
Materials and methods
C. elegans strains
Strains sphk-1(ok1097) and hyl-1(gk203) were provided by the
Caenorhabditis Genetics Center, which is funded by the NIH
National Center for Research Resources (NCRR). The wild-type
reference strain was N2 Bristol. sphk-1(ok1097) was outcrossed
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10 times and used for all experiments. All other strains used were
outcrossedmore than four times. In addition, the following strains
were used (strain information is at http://www.wormbase.org):
cha-1(p1182), cpx-1(ok1522), dgk-1(nu62), egl-8(sa47), egl-30(ad806),
egl-30(js126gf), gar-1(ok755), gar-3(gk305), pkc-1(nj3), slo-1(ky399gf),
tomo-1(nu468), unc-13(s69), unc-18(md299), unc-57(e406), unc-
73(ce362), unc-104(e1265), nuIs152[ttx-3-mRFP, Punc-129-
GFP-snb-1]II, nuIs159[ttx-3-mRFP, Punc-129-GFP-syd-2]III,
nuIs162[myo-2-GFP, Punc-129-snn-1-Venus]III, nuIs166[myo-
2-GFP, Punc-129-unc-10:GFP]III, nuIs168[myo-2-GFP, Punc-129-
Venus-rab-3]IV, nuIs169[myo-2-GFP, Punc-129-gelsolin-Venus]III,
nuIs175[myo-2-RFP, Punc-129-RFP-snb-1]X, nuIs183[myo-2-GFP,
Punc-129-nlp-21-Venus]III, nuIs184[myo-2-GFP, Punc-129-apt-4-
GFP]X, nuIs197[myo-2-GFP, Punc-129-sphk-1-GFP]III, nuIs214
[myo-2-GFP, Punc-129-itsn-1-GFP]III, and nuIs321[myo-2-GFP,
Punc-17-RFP]. All integrated transgenes were outcrossed 10 times.
Molecular biology
The promoter fragment of sphk-1 was amplified by PCR from
mixed-stage genomic DNA. sphk-1 mutations were made by
QuikChange PCR (Stratagene) targeting the following deletions:
kinase-dead (KD1) (S101A, G102A, D103A, G104A, and L105A),
kinase-dead (KD2) (G184D, S185D, G185D, and N186D), and
DCaM (F271A and I272Q). For a full list of primers used, see the
Supplemental Material. The cDNA was used to make the
following plasmids by standard molecular biology techniques
(plasmid name[promoter-gene-marker]): pDS221[Punc-129-sphk-
1-GFP], pDS300[Psphk-1-GFP-NLS], pDS301[Punc-129-sphk-1-
mCherry], pDS302[Pmyo-3-sphk-1-GFP], pDS303[Psphk-1-sphk-
1-GFP], pDS304[Psnb-1-sphk-1-GFP], pDS305[Punc-129-sphk-1],
pDS306[Punc-129-sphk-1(CaM)-GFP], pDS307[Punc-129-sphk-
1(KD)], pDS308[Pmyo-3-sphk-1], pDS309[Psphk-1-sphk-1(KD)-GFP],
pDS323[Punc-129-gar-3], and pDS361[Psnb-1-sphk-1(CaM)-GFP].
Transgenic lines
Transgenic strains were generated by injecting either N2, sphk-
1(ok1097), sphk-1(ok1097);nuIs152, or nuIs197 animals with
expression constructs (10–25 ng/mL) and the coinjection marker
KP#708 (Pttx-3-rfp, 40 ng/mL) or KP#1106 (Pmyo-2-gfp 10 ng/mL).
Microinjection was performed using standard techniques as
previously described (Mello et al. 1991). At least three lines for
each transgene were examined, and either an average of the
three transgenes or results from a single, representative transgene
are shown. For transgene information, see the Supplemental
Material.
Behavioral analysis of locomotion activity and sensitivity
to aldicarb
For analysis of locomotion activity, the number of body bends
per minute was counted for L4 worms on normal growthmedium
(NGM) plates in the presence of food, as previously described
(McMullan et al. 2006). Thirty worms were scored for each group.
For analysis of sensitivity to inhibitors of acetylcholinesterase,
paralysis of adult worms was scored every 10 min, starting at 40
min, using 0.5–2 mM aldicarb (Chem Services). For each experi-
ment, three plates of 20worms per genotypewere placed onNGM
plates supplemented with aldicarb, and the number of worms
paralyzed on each plate was counted to extract the percent
paralyzed at each time point per genotype. The percentages were
averaged at each time point per genotype and plotted graphically.
For each experiment, the genotypewas blind to the scorer, and the
analysis was repeated at least two times. Statistical differences
were determined at each time point by Student’s t-tests.
Electrophysiology
Electrophysiology was done on dissected C. elegans as described
(Richmond and Jorgensen 1999). Worms were superfused in an
extracellular solution containing 127 mM NaCl, 5 mM KCl, 26
mM NaHCO3, 1.25 mM NaH2PO4, 20 mM glucose, 3 mM
CaCl2, and 3 mM MgCl2 (330 mOsm at pH 7.2), bubbled with
5%CO2 and 95%O2 at 20°C.Whole-cell recordings were carried
out at 60 mV using an internal solution containing 105 mM
CH3O3SCs, 10 mM CsCl, 15 mM CsF, 4 mM MgCl2, 5 mM
EGTA, 0.25 mM CaCl2, 10 mM HEPES, and 4 mMNa2ATP (315
mOsm, adjusted to pH 7.2 using CsOH). Under these conditions,
we only observed endogenous ACh EPSCs. All other recording
conditions were as described (Sieburth et al. 2007). Statistical
significance was determined by Student’s t-test.
Microscopy and analysis
Fluorescence microscopy experiments were performed as pre-
viously described (Ch’ng et al. 2008). Briefly, adult worms were
paralyzed using 2,3-butanedione monoxime (BDM, 30 mg/mL;
Sigma) and mounted on 2% agarose pads for imaging. Images of
synapses were captured from dorsal axons of DA neurons near the
posterior gonadal bend of the worm. Approximately 30 worms
(spanning 500 synapses) were imaged for all experiments. For all
fluorescencemicroscopy experiments, imageswere capturedwith
a Nikon eclipse 90i microscope equipped with a Nikon PlanApo
1003 objective (NA = 1.4) and a Photometrics Coolsnap ES2
camera. Metamorph 7.0 software (Universal Imaging/Molecular
Devices) was used to capture serial image stacks, and the
maximum intensity projection was used for analysis of the dorsal
cords. Line scans of themaximum intensity projection imagewere
also recorded usingMetamorph. The fluorescence intensity values
were then quantified using Puncta 6.0 software written with Igor
Pro (Wavemetrics), as previously described (Dittman and Kaplan
2006; Ch’ng et al. 2008). For all experiments, fluorescence values
were normalized to the values of 0.5 mm FluoSphere beads
(Invitrogen) captured during each imaging session. This was
performed to provide a standard for comparing absolute fluores-
cence levels between animals from different sessions.
We found that the conditions used for imaging showed that
SPHK-1-GFP, UNC-10-GFP, and GFP-SYD-2 were predominantly
localized to synaptic puncta, as determined previously (Ch’ng et al.
2008). There was little or no difference between their axonal
fluorescence and the autofluorescence observed atC. elegans axons.
Therefore, we excluded the axonal fluorescence in our analysis for
these markers (see Fig. 2; Supplemental Tables S2, S3). In addition,
we performed analyses of SPHK-1 localization with either SPHK-1-
GFP or SPHK-1-mCherry fusion proteins paired with other fluo-
rescently tagged synaptic markers because the fusion proteins
SPHK-1-GFP and SPHK-1-mCherry showed similar localization
patterns (Supplemental Fig. S2) when colocalized in the same cell.
Pharmacology
Adult animals were pretreated for 2 h on NGM plates supple-
mented with arecoline (15mM inM9; Sigma), serotonin (10mM)
or SKI (50 mM in DMSO; EMD Chemicals). For controls, NMG
plates were supplemented with a control solvent (M9, DMSO, or
water) for the respective experiments. For aldicarb experiments,
drugs were also added to the aldicarb plates.
Statistical analysis
For all experiments comparing two samples, a Student’s t-test
was used to determine significance, set at P < 0.05. For experiments
Chan et al.
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comparing multiple groups, significance was determined by per-
forming a one-way ANOVA and a Tukey post-hoc analysis. Pro-
pagation of standard error of the mean (SEM) was performed for all
comparisons. Significance was also set at P < 0.05. Full charts of
statistical analyses for all experimental comparisons are available
in the Supplemental Material (Supplemental Tables S1–S3).
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